ENvue Medical, Inc. (FEED)

Market Cap	951.43K -81.6%
Revenue (ttm)	1.93M -17.7%
Net Income	-49.19M
EPS	-206.88
Shares Out	923.72K
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,222,262
Open	3.340
Previous Close	3.350
Day's Range	0.840 - 3.420
52-Week Range	0.840 - 208.800
Beta	1.37
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About ENvue Medical

ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers UroShield Ultra, which is desig...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 14
• Stock Exchange: OTCMKTS
• Ticker Symbol: FEED

Financial Performance

In 2025, ENvue Medical's revenue was $2.55 million, a decrease of -0.20% compared to the previous year's $2.56 million. Losses were -$16.78 million, 352.8% more than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 16, 2026

Data Sources Report a data error